Product
Acetaminophen/paracetamol
1 clinical trial
1 indication
Indication
Lupus NephritisClinical trial
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescent Patients With Active Class III or IV Lupus Nephritis, Including an Evaluation of Open Label Safety and PK in a Cohort of Pediatric Patients (Aged 5 to < 12)Status: Recruiting, Estimated PCD: 2026-03-31